FDG-PET
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
National Center for Research Resources (NCRR)
Overview
FDG-PET is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
FDG-PET clinical trials
Explore related
Medical disclaimer. This page summarizes research about FDG-PET for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.